The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MONDAY, Feb. 9, 2026 (HealthDay News) — Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product ...

NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its ⁠original ⁠sexual-health franchises matured, may have overstepped with a risky launch ⁠of ...

Share on Pinterest Hims & Hers has withdrawn its low cost compounded weight loss pill after pressure from top U.S. health officials and a major lawsuit. Image courtesy of Novo Nordisk Hims & Hers ...

Hims & Hers reversed course on its launch of a cheaper, copycat version of Novo Nordisk’s GLP-1 weight loss pill amid legal action. In a Feb. 7 social media post, the San Francisco-based telehealth ...

Two days after offering compounded versions of oral Wegovy, telehealth company Hims & Hers pulled the product from its platform amid pressure from HHS and Novo Nordisk. On Feb. 5, Hims & Hers began ...

Novo Nordisk said it filed a federal lawsuit Feb. 9 against telehealth provider Hims & Hers, alleging the company infringed on Novo's patent by selling versions of its blockbuster weight-loss drug ...

Strive Pharmacy, an Arizona-based pharmacy partner for Hims & Hers (HIMS), is not planning to introduce a compounded version of Novo Nordisk’s (NVO) newly launched oral obesity therapy, the Wegovy ...

NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health (HIMS.N), opens new tab, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a ...